PEAK6 Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

PEAK6 Group’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,708	Closed	-$299K	–	5186
2016 Q3	$299K	Buy	+2,708	New	+$359K	﹤0.01%	2817
2016 Q2	–	Sell	-1,758	Closed	-$249K	–	4870
2016 Q1	$252K	Sell	1,758 -280	-14%	-$39.8K	﹤0.01%	2910
2015 Q4	$315K	Sell	2,038 -17,244	-89%	-$2.52M	﹤0.01%	3023
2015 Q3	$2.75M	Buy	19,282 +6,844	+55%	+$957K	0.01%	1315
2015 Q2	$1.79M	Buy	12,438 +10,810	+664%	+$1.54M	0.01%	1562
2015 Q1	$230K	Buy	+1,628	New	+$251K	﹤0.01%	3330

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Group's TARO Position: Q4 2016 in Review

PEAK6 Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2016, closing a stake of 2,708 shares — an estimated $299K sold.

PEAK6 Group first reported a position in TARO in Q1 2015 and held it in 6 quarters. The position peaked at $2.75M in Q3 2015. 151 funds tracked by Wall St. Rank hold TARO as of Q4 2016.

PEAK6 Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2016 after selling out during the quarter.
PEAK6 Group sold 2,708 Taro Pharmaceutical Industries Ltd. shares in Q4 2016, an estimated $299K.
PEAK6 Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2015 and held it in 6 quarters.
PEAK6 Group's Taro Pharmaceutical Industries Ltd. position peaked at $2.75M in Q3 2015.
151 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2016.

Based on PEAK6 Group's 13F filing for Q4 2016, filed 13 Feb 2017.